AU612151B2 - Canine coronavirus vaccine - Google Patents

Canine coronavirus vaccine Download PDF

Info

Publication number
AU612151B2
AU612151B2 AU17476/88A AU1747688A AU612151B2 AU 612151 B2 AU612151 B2 AU 612151B2 AU 17476/88 A AU17476/88 A AU 17476/88A AU 1747688 A AU1747688 A AU 1747688A AU 612151 B2 AU612151 B2 AU 612151B2
Authority
AU
Australia
Prior art keywords
ccv
vaccine
cell
infection
canine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU17476/88A
Other languages
English (en)
Other versions
AU1747688A (en
Inventor
Michael Alonzo Gill
Stephen W. May
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Norden Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Laboratories Inc filed Critical Norden Laboratories Inc
Publication of AU1747688A publication Critical patent/AU1747688A/en
Application granted granted Critical
Publication of AU612151B2 publication Critical patent/AU612151B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AU17476/88A 1987-06-08 1988-06-08 Canine coronavirus vaccine Ceased AU612151B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US059437 1987-06-08
US07/059,437 US4904468A (en) 1987-06-08 1987-06-08 Canine coronavirus vaccine

Publications (2)

Publication Number Publication Date
AU1747688A AU1747688A (en) 1988-12-08
AU612151B2 true AU612151B2 (en) 1991-07-04

Family

ID=22022943

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17476/88A Ceased AU612151B2 (en) 1987-06-08 1988-06-08 Canine coronavirus vaccine

Country Status (20)

Country Link
US (1) US4904468A (fr)
EP (1) EP0295057B1 (fr)
JP (1) JP2655876B2 (fr)
KR (1) KR970000233B1 (fr)
AT (1) ATE91902T1 (fr)
AU (1) AU612151B2 (fr)
CA (1) CA1337267C (fr)
DE (1) DE3882599T2 (fr)
DK (1) DK175410B1 (fr)
ES (1) ES2058283T3 (fr)
FI (1) FI87531C (fr)
HU (1) HU203984B (fr)
IE (1) IE63006B1 (fr)
IL (1) IL86635A0 (fr)
MY (1) MY103575A (fr)
NO (1) NO176004C (fr)
NZ (1) NZ224865A (fr)
PH (1) PH27018A (fr)
PT (1) PT87668B (fr)
ZA (1) ZA884040B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645417B2 (en) * 1991-04-25 1994-01-13 Intervet International B.V. Canine coronavirus subunit vaccine

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
US5232694A (en) * 1989-05-03 1993-08-03 Akzo N.V. Canine corona virus vaccine
US5672350A (en) * 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
US5643577A (en) * 1990-04-24 1997-07-01 The University Of Newcastle Research Associates Limited Oral vaccine comprising antigen surface-associated with red blood cells
US5882649A (en) * 1990-04-24 1999-03-16 Flustat Pty. Ltd. Oral vaccine comprising antigen surface-associated with red blood cells
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
EP0524672A1 (fr) * 1991-06-27 1993-01-27 Duphar International Research B.V Vaccin contre le CCV
US20040063093A1 (en) * 1992-04-08 2004-04-01 Pfizer, Inc. Recombinant feline coronavirus S proteins
ES2182827T3 (es) * 1992-05-08 2003-03-16 Pfizer Gen del virus corona canino y usos del mismo.
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
ES2355702T3 (es) * 2005-10-26 2011-03-30 Canio Buonavoglia Coronavirus canino pantrópico.
US7761389B2 (en) 2007-08-23 2010-07-20 Gm Global Technology Operations, Inc. Method for anomaly prediction of battery parasitic load
JP2013507925A (ja) * 2009-10-14 2013-03-07 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ アライグマからのイヌパルボウイルス−２に関連するウイルスの分離
US9809800B2 (en) 2012-11-22 2017-11-07 Asahi Kasei Medical Co., Ltd. Method for producing parvovirus having high infectivity titer
CN106290880B (zh) * 2015-05-27 2019-01-04 江苏雷森生物科技有限公司 一种用于犬冠状病毒的免疫层析用试剂组合物及检测方法
EP3372677B8 (fr) 2015-11-06 2019-09-25 Asahi Kasei Medical Co., Ltd. Procédé de production d'un parvovirus possédant un titre élevé d'infectivité et une grande pureté
CN110903387A (zh) * 2019-12-17 2020-03-24 吉林省纽卓莱生物科技有限责任公司 一种犬冠状病毒免疫球蛋白F(ab′)2及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005806A1 (fr) * 1985-03-29 1986-10-09 National Research Development Corporation Proteine "pointe" du virus de la bronchite infectieuse

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645417B2 (en) * 1991-04-25 1994-01-13 Intervet International B.V. Canine coronavirus subunit vaccine

Also Published As

Publication number Publication date
EP0295057B1 (fr) 1993-07-28
FI87531B (fi) 1992-10-15
HU203984B (en) 1991-11-28
ATE91902T1 (de) 1993-08-15
US4904468A (en) 1990-02-27
PH27018A (en) 1993-02-01
ZA884040B (en) 1989-09-27
IE881689L (en) 1988-12-08
NO176004B (no) 1994-10-10
MY103575A (en) 1993-08-28
FI882689A0 (fi) 1988-06-07
NO882500D0 (no) 1988-06-07
FI882689L (fi) 1988-12-09
KR890000105A (ko) 1989-03-11
DK301588A (da) 1988-12-09
NZ224865A (en) 1990-12-21
DE3882599D1 (de) 1993-09-02
FI87531C (fi) 1993-01-25
EP0295057A2 (fr) 1988-12-14
PT87668B (pt) 1992-09-30
NO882500L (no) 1988-12-09
JP2655876B2 (ja) 1997-09-24
EP0295057A3 (en) 1989-12-27
AU1747688A (en) 1988-12-08
DK175410B1 (da) 2004-09-27
NO176004C (no) 1995-01-18
JPS63316739A (ja) 1988-12-26
CA1337267C (fr) 1995-10-10
IE63006B1 (en) 1995-03-22
IL86635A0 (en) 1988-11-30
PT87668A (pt) 1988-07-01
HUT46858A (en) 1988-12-28
DE3882599T2 (de) 1994-02-10
KR970000233B1 (ko) 1997-01-08
ES2058283T3 (es) 1994-11-01
DK301588D0 (da) 1988-06-02

Similar Documents

Publication Publication Date Title
AU612151B2 (en) Canine coronavirus vaccine
EP0329264B1 (fr) Vaccins vétérinaires
MXPA04011218A (es) Vacuna combinada mejorada contra mycoplasma hyopneumoniae y virus porcinos.
GB2282811A (en) Viral vaccine for the prevention of porcine reproductive and respiratory syndrome
EP0101348A2 (fr) Vaccin contre la proventriculite aviaire, réovirus de la proventriculite aviaire, procédé de préparation du vaccin et procédé pour protéger la volaille contre la proventriculite
EP1024189B1 (fr) Nouvelle classe antigénique de reovirus aviaires
CA1184115A (fr) Vaccins contre la bronchite infectieuse des volailles et procede de preparation
CA1183452A (fr) Vaccin contre la rage
KR100302522B1 (ko) 고양이장코로나바이러스로부터의개코로나바이러스왁찐
EP0612532A2 (fr) Vaccin contre le coronavirus canin à partir de coronavirus entérique félin
US5213795A (en) Encephalomyocarditis virus vaccine
McKercher A Comparison of the Viruses of Infectious Bovine Rhinotracheitis (IBR), Infectious Pustular Vulvovaginitis (IPV), and Rinderpest: Part I. Studies of Antigenic Relationships
JP2892767B2 (ja) イヌコロナウイルスワクチン
NZ336937A (en) Infectious bursitis vaccine comprising an Infectious Burstitis virus capable of protecting poultry
AU721367B2 (en) Canine coronavirus vaccine from feline enteric coronavirus
Ghadakchi et al. Efficacy of experimental inactivated vaccine for infectious bronchitis disease.
Donis THE PROTEINS OF BOVINE VIRAL DIARRHEA VIRUS: CHARACTERIZATION, BIOTYPE-SPECIFIC DIFFERENCES, AND IMMUNOLOGICAL PROPERTIES
Brako EQUINE HERPESVIRUSES TYPE 1 AND 2: GROWTH AND CYTOPATHIC EXPRESSION IN ORGAN CULTURES OF EQUINE RESPIRATORY EPITHELIUM AND IN CELL CULTURES (ELECTRON MICROSCOPY, MORPHOGENESIS)
Reddy et al. Biotechnology, Veterinary college, Madras. Karber (1931) and expressed as log, TGD,/was adapted to A72 cell line and masterseed* ºº
Mattson Properties of six South Dakota bovine picornaviruses
HK1012293A (en) Canine coronavirus vaccine from feline enteric coronavirus
MXPA99007134A (en) Infectious bursitis vaccine
CA2146321A1 (fr) Vaccins tres puissants